Among breast cancers, TNBC are considered the most aggressive form and no targeted therapy is currently available due to a lack of specific targets.1 Here, we show that PRICKLE1 is overexpressed in TNBC and is a poor-prognosis marker. The gene discussed is PRICKLE1; the disease is breast carcinoma.